EPR Issue 1 includes articles on manufacturing, drug delivery, environmental monitoring, analytical techniques and more.
General Manager Brian Morrissey discusses his company’s acquisition of fellow Beta-Lactam manufacturer Athlone Laboratories and its implications for an evolving industry.
Sartorius BIA Separations illustrates a promising alternative approach for efficient lentiviral vector purification that delivers a scalable, GMP-ready biomanufacturing solution.
AI/ML is not replacing formulation scientists or process engineers; it is just amplifying their expertise.
Dave Elder reflects on the array of applications for AI to facilitate successful drug development, though proof remains elusive.